Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II)

Author:

Asselah Tarik1,Alami Negar Niki2,Moreno Christophe3,Pol Stanislas456,Karatapanis Stylianos7,Gschwantler Michael8ORCID,Horsmans Yves9,Elefsiniotis Ioannis10,Larrey Dominique11,Ferrari Carlo12,Rizzetto Mario13,Orlandini Alessandra14,Calleja Jose Luis15,Bruno Savino16,Schnell Gretja2,Qaqish Roula17,Redman Rebecca2,Pilot-Matias Tami2,Kopecky-Bromberg Sarah2,Yu Yao2,Mobashery Niloufar2

Affiliation:

1. Hopital Beaujon; Clichy France

2. AbbVie, Inc; Chicago Illinois

3. CUB Hôpital Erasme; Université Libre de Bruxelles; Brussels Belgium

4. Université Paris Descartes; Paris France

5. Hepatology Department; Cochin Hospital, APHP; Paris France

6. INSERM U1223, UMS-20 and Center for Translational Science; Institut Pasteur; Paris France

7. Department of Internal Medicine; General Hospital of Rhodes; Rhodes Greece

8. Medizinische Abteilung mit Gastroenterologie, Hepatologie, Endoskopie und Ambulanz; Wilhelminenspital; Wien Austria

9. Cliniques Universitaires Saint-Luc, Department of Gastroenterology; Université catholique de Louvain; Brussels Belgium

10. Academic Department of Internal Medicine-Hepatology Unit, General Oncology Hospital of Kifisia “Agioi Anargyroi”; National and Kapodistrian University of Athens; Athens Greece

11. Liver Unit-IRB-INSERM1040; Hôpital Saint Eloi; Montpellier France

12. Università degli Studi di Parma; Parma Italy

13. University of Torino; Turin Italy

14. Azienda Ospedaliero-Universitaria di Parma; Parma Italy

15. Liver Unit, Puerta de Hierro University Hospital, Instituto de Investigación Sanitaria Puerta de Hierro-Majadajonda, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; Majadahonda Madrid Spain

16. Department of Biomedical Sciences; Humanitas University, Humanitas Research Hospital; Milan Italy

17. Pharmacyclics LLC; Sunnyvale California USA

Funder

AbbVie

Publisher

Wiley

Subject

General Medicine

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3